The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.
As of close of business last night, Phio Pharmaceuticals Corp’s stock clocked out at $1.75, down -4.89% from its previous closing price of $1.84. In other words, the price has decreased by -$4.89 from its previous closing price. On the day, 0.18 million shares were traded. PHIO stock price reached its highest trading level at $1.86 during the session, while it also had its lowest trading level at $1.71.
Ratios:
To gain a deeper understanding of PHIO’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 10.58 and its Current Ratio is at 10.58. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, H.C. Wainwright on August 05, 2020, initiated with a Buy rating and assigned the stock a target price of $4.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on May 21 ’25 when Bitterman Robert J bought 3,000 shares for $1.77 per share. The transaction valued at 5,310 led to the insider holds 22,449 shares of the business.
Bitterman Robert J bought 1,200 shares of PHIO for $2,136 on May 22 ’25. The Chairman, Pres & CEO now owns 23,649 shares after completing the transaction at $1.78 per share. On May 20 ’25, another insider, Ferrara Robert L, who serves as the Director of the company, bought 2,500 shares for $1.82 each. As a result, the insider paid 4,550 and bolstered with 13,166 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PHIO now has a Market Capitalization of 8396762 and an Enterprise Value of 3123114.
Stock Price History:
The Beta on a monthly basis for PHIO is 0.82, which has changed by -0.74942726 over the last 52 weeks, in comparison to a change of 0.09362543 over the same period for the S&P500. Over the past 52 weeks, PHIO has reached a high of $9.79, while it has fallen to a 52-week low of $0.97. The 50-Day Moving Average of the stock is 1.16%, while the 200-Day Moving Average is calculated to be -25.60%.
Shares Statistics:
It appears that PHIO traded 3.10M shares on average per day over the past three months and 315590 shares per day over the past ten days. A total of 4.78M shares are outstanding, with a floating share count of 4.77M. Insiders hold about 0.67% of the company’s shares, while institutions hold 3.99% stake in the company. Shares short for PHIO as of 1745971200 were 274687 with a Short Ratio of 0.09, compared to 1743379200 on 78709. Therefore, it implies a Short% of Shares Outstanding of 274687 and a Short% of Float of 5.75.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
